Literature DB >> 18547762

Cancer incidence and mortality in France over the period 1980-2005.

A Belot1, P Grosclaude, N Bossard, E Jougla, E Benhamou, P Delafosse, A-V Guizard, F Molinié, A Danzon, S Bara, A-M Bouvier, B Trétarre, F Binder-Foucard, M Colonna, L Daubisse, G Hédelin, G Launoy, N Le Stang, M Maynadié, A Monnereau, X Troussard, J Faivre, A Collignon, I Janoray, P Arveux, A Buemi, N Raverdy, C Schvartz, M Bovet, L Chérié-Challine, J Estève, L Remontet, M Velten.   

Abstract

BACKGROUND: The objective of this study was to provide updated estimates of national trends in cancer incidence and mortality for France for 1980-2005.
METHODS: Twenty-five cancer sites were analysed. Incidence data over the 1975-2003 period were collected from 17 registries working at the department level, covering 16% of the French population. Mortality data for 1975-2004 were provided by the Inserm. National incidence estimates were based on the use of mortality as a correlate of incidence, mortality being available at both department and national levels. Observed incidence and mortality data were modelled using an age-cohort approach, including an interaction term. Short-term predictions from that model gave estimates of new cancer cases and cancer deaths in 2005 for France.
RESULTS: The number of new cancer cases in 2005 was approximately 320,000. This corresponds to an 89% increase since 1980. Demographic changes were responsible for almost half of that increase. The remainder was largely explained by increases in prostate cancer incidence in men and breast cancer incidence in women. The relative increase in the world age-standardised incidence rate was 39%. The number of deaths from cancer increased from 130,000 to 146,000. This 13% increase was much lower than anticipated on the basis of demographic changes (37%). The relative decrease in the age-standardised mortality rate was 22%. This decrease was steeper over the 2000-2005 period in both men and women. Alcohol-related cancer incidence and mortality continued to decrease in men. The increasing trend of lung cancer incidence and mortality among women continued; this cancer was the second cause of cancer death among women. Breast cancer incidence increased regularly, whereas mortality has decreased slowly since the end of the 1990s.
CONCLUSION: This study confirmed the divergence of cancer incidence and mortality trends in France over the 1980-2005 period. This divergence can be explained by the combined effects of a decrease in the incidence of the most aggressive cancers and an increase in the incidence of less aggressive cancers, partly due to changes in medical practices leading to earlier diagnoses.

Entities:  

Mesh:

Year:  2008        PMID: 18547762     DOI: 10.1016/j.respe.2008.03.117

Source DB:  PubMed          Journal:  Rev Epidemiol Sante Publique        ISSN: 0398-7620            Impact factor:   1.019


  58 in total

1.  Estimating penetrance from multiple case families with predisposing mutations: extension of the 'genotype-restricted likelihood' (GRL) method.

Authors:  Bernard Bonaïti; Valérie Bonadona; Hervé Perdry; Nadine Andrieu; Catherine Bonaïti-Pellié
Journal:  Eur J Hum Genet       Date:  2010-10-06       Impact factor: 4.246

2.  Menopausal hormone therapy and risks of colorectal adenomas and cancers in the French E3N prospective cohort: true associations or bias?

Authors:  Sophie Morois; Agnès Fournier; Françoise Clavel-Chapelon; Sylvie Mesrine; Marie-Christine Boutron-Ruault
Journal:  Eur J Epidemiol       Date:  2012-05-29       Impact factor: 8.082

Review 3.  Challenging treatment decision-making in older urologic cancer patients.

Authors:  Guillaume Ploussard; Gilles Albrand; François Rozet; Hervé Lang; Elena Paillaud; Pierre Mongiat-Artus
Journal:  World J Urol       Date:  2013-08-30       Impact factor: 4.226

4.  Determinants of quality of life among long-term breast cancer survivors.

Authors:  Wai-On Chu; Pegdwende Olivia Dialla; Patrick Roignot; Marie-Christine Bone-Lepinoy; Marie-Laure Poillot; Charles Coutant; Patrick Arveux; Tienhan Sandrine Dabakuyo-Yonli
Journal:  Qual Life Res       Date:  2016-02-25       Impact factor: 4.147

5.  Vemurafenib and concomitant stereotactic radiation for the treatment of melanoma with spinal metastases: A case report.

Authors:  Dinu Stefan; Hosni Popotte; Andreea Raluca Stefan; Audrey Tesniere; Aurélie Tomaszewski; Paul Lesueur; Jean-Louis Habrand; Laurence Verneuil
Journal:  Rep Pract Oncol Radiother       Date:  2015-09-29

6.  Population-based study of ovarian cancer in Côte d'Or: prognostic factors and trends in relative survival rates over the last 20 years.

Authors:  Zeinab Hamidou; Sylvain Causeret; Tienhan S Dabakuyo; Julie Gentil; Laurent Arnould; Patrick Roignot; Thierry Altwegg; Marie-Laure Poillot; Franck Bonnetain; Patrick Arveux
Journal:  BMC Cancer       Date:  2010-11-10       Impact factor: 4.430

7.  Age-period-cohort modelling of non-Hodgkin's lymphoma incidence in a French region: a period effect compatible with an environmental exposure.

Authors:  Jean-François Viel; Evelyne Fournier; Arlette Danzon
Journal:  Environ Health       Date:  2010-08-08       Impact factor: 5.984

8.  Head and neck cancers in France: an analysis of the hospital medical information system (PMSI) database.

Authors:  Jean Lacau St Guily; Isabelle Borget; Alexandre Vainchtock; Vanessa Rémy; Claire Takizawa
Journal:  Head Neck Oncol       Date:  2010-09-01

9.  Polymorphisms in arachidonic acid metabolism-related genes and the risk and prognosis of colorectal cancer.

Authors:  Shuying Li; Xiaojuan Zhao; Zhiwei Wu; Ye Li; Lin Zhu; Binbin Cui; Xinshu Dong; Suli Tian; Fulan Hu; Yashuang Zhao
Journal:  Fam Cancer       Date:  2013-12       Impact factor: 2.375

Review 10.  Multidisciplinary approach of early breast cancer: the biology applied to radiation oncology.

Authors:  Céline Bourgier; Mahmut Ozsahin; David Azria
Journal:  Radiat Oncol       Date:  2010-01-14       Impact factor: 3.481

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.